ES2253156T5 - Anticuerpos capaces de detectar de manera selectiva isoformas del prión PrPSc - Google Patents

Anticuerpos capaces de detectar de manera selectiva isoformas del prión PrPSc Download PDF

Info

Publication number
ES2253156T5
ES2253156T5 ES00111108T ES00111108T ES2253156T5 ES 2253156 T5 ES2253156 T5 ES 2253156T5 ES 00111108 T ES00111108 T ES 00111108T ES 00111108 T ES00111108 T ES 00111108T ES 2253156 T5 ES2253156 T5 ES 2253156T5
Authority
ES
Spain
Prior art keywords
tyr
gln
glu
thr
arg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00111108T
Other languages
English (en)
Spanish (es)
Other versions
ES2253156T3 (es
Inventor
Dr. Curin-Serbec
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Blood Transfusion Centre of Slovenia
Original Assignee
Blood Transfusion Centre of Slovenia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8168816&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2253156(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Blood Transfusion Centre of Slovenia filed Critical Blood Transfusion Centre of Slovenia
Application granted granted Critical
Publication of ES2253156T3 publication Critical patent/ES2253156T3/es
Publication of ES2253156T5 publication Critical patent/ES2253156T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES00111108T 2000-05-23 2000-05-23 Anticuerpos capaces de detectar de manera selectiva isoformas del prión PrPSc Expired - Lifetime ES2253156T5 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00111108A EP1158003B2 (en) 2000-05-23 2000-05-23 Antibodies capable to selectively detect prion PrP Sc isoforms

Publications (2)

Publication Number Publication Date
ES2253156T3 ES2253156T3 (es) 2006-06-01
ES2253156T5 true ES2253156T5 (es) 2013-04-30

Family

ID=8168816

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00111108T Expired - Lifetime ES2253156T5 (es) 2000-05-23 2000-05-23 Anticuerpos capaces de detectar de manera selectiva isoformas del prión PrPSc

Country Status (14)

Country Link
EP (1) EP1158003B2 (https=)
JP (1) JP5042430B2 (https=)
KR (1) KR100829447B1 (https=)
CN (1) CN1250572C (https=)
AR (1) AR029098A1 (https=)
AT (1) ATE312848T1 (https=)
AU (2) AU2001284355B2 (https=)
CA (1) CA2407905C (https=)
DE (1) DE60024787T3 (https=)
DK (1) DK1158003T4 (https=)
ES (1) ES2253156T5 (https=)
HU (1) HU229454B1 (https=)
PL (1) PL208292B1 (https=)
WO (1) WO2001090191A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003059386A2 (en) * 2002-01-18 2003-07-24 Cytos Biotechnology Ag Prion protein carrier-conjugates
EP1596199A1 (en) * 2004-05-14 2005-11-16 Prionics AG Method for the detection of disease-related prion
JP4246777B1 (ja) * 2007-11-20 2009-04-02 森永乳業株式会社 異常型プリオン蛋白質結合剤および異常型プリオン蛋白質の検出方法
EP2135880A1 (en) * 2008-06-17 2009-12-23 Heinrich-Heine-Universität Düsseldorf Anti-prion protein antibody fragment
AU2009301580B2 (en) 2008-10-06 2015-11-26 The University Of British Columbia Methods and systems for predicting misfolded protein epitopes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ246059A (en) * 1991-12-03 1995-08-28 Proteus Molecular Design Synthetic polypeptides with at least one antigenic site of a prion protein, methods of their use and manufacture, antibodies thereto, compositions and kits
DE852011T1 (de) * 1995-09-14 2001-10-11 Scripps Res Inst La Jolla Für natives prp-sc spezifische antikörper
EP0861900A1 (en) † 1997-02-21 1998-09-02 Erziehungsdirektion Of The Canton Zurich Immunological detection of prions
DE19741607A1 (de) * 1997-09-20 1999-03-25 Prionics Ag Synthetische Polypeptide zur Diagnose und Therapie von Prionerkrankungen

Also Published As

Publication number Publication date
DE60024787T3 (de) 2013-06-06
CN1441811A (zh) 2003-09-10
AU8435501A (en) 2001-12-03
AU2001284355B2 (en) 2005-11-10
PL208292B1 (pl) 2011-04-29
EP1158003B2 (en) 2012-12-26
EP1158003A1 (en) 2001-11-28
HUP0302413A2 (hu) 2003-10-28
HU229454B1 (en) 2013-12-30
WO2001090191A3 (en) 2002-06-20
ATE312848T1 (de) 2005-12-15
EP1158003B1 (en) 2005-12-14
PL360139A1 (en) 2004-09-06
WO2001090191A2 (en) 2001-11-29
ES2253156T3 (es) 2006-06-01
JP2003534000A (ja) 2003-11-18
DK1158003T4 (da) 2013-04-08
KR20030014234A (ko) 2003-02-15
KR100829447B1 (ko) 2008-05-15
CA2407905A1 (en) 2001-11-29
DK1158003T3 (da) 2006-05-01
JP5042430B2 (ja) 2012-10-03
DE60024787T2 (de) 2006-09-07
CN1250572C (zh) 2006-04-12
CA2407905C (en) 2012-08-14
AR029098A1 (es) 2003-06-04
DE60024787D1 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
ES2368907T3 (es) Procedimientos y composiciones inmunológicas para el tratamiento de la enfermedad de alzheimer.
US7259246B2 (en) Immunological detection of prions
ES2404295T3 (es) Método para diagnosticar y tratar preeclampsia o eclampsia
ES2453941T5 (es) Anticuerpos monoclonales contra la proteína beta amiloide y usos de los mismos
PT1160256E (pt) Anticorpo monoclonal específico para o peptídeo beta-a4 (1-42)
KR101166012B1 (ko) 프리온-특이적 펩티드 시약
US20120107321A1 (en) Antibodies And Epitopes Specific To Misfolded Prion Protein
BR112014026755B1 (pt) Anticorpos contra claudin 18.2 úteis no diagnóstico de câncer
WO1999066956A1 (en) IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP)
EP0690723A1 (en) Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides
ES2253156T5 (es) Anticuerpos capaces de detectar de manera selectiva isoformas del prión PrPSc
JP2000146982A (ja) Ｍａファミリ―ポリペプチド及び抗―Ｍａ抗体
NO321571B1 (no) Fremgangsmate for immunologisk pavisning av prionsykdom, diagnostisk testsett til slik pavisning, samt anvendelse av testsettet.
US20050163776A1 (en) Treatment of tse infection
KR20100122902A (ko) 얼리키아 샤피엔시스에 대한 백신 및 진단제
ES3033808T3 (en) Anti- isoasp7 amyloid beta (abeta) antibodies and uses thereof
US7098317B1 (en) Antibodies capable to selectively detect prion PrPSc isoforms
ES2269353T3 (es) Nueva proteina ulip/crmp humana y su utilizacion en el diagnostico y la terapia de canceres y de sindromes neurologicos paraneoplasicos.
JP2008536803A (ja) 精子タンパク質に対する新規卵受容体
JP2000514430A (ja) 精子抗原を含む免疫避妊組成物およびその使用方法
ES2625606T3 (es) Prevención y tratamiento de la enfermedad sinucleinopatía y amiloide
JP2005145936A (ja) 抗Ｋａｎｋモノクローナル抗体